OLYMPUS CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,256 JPY | +2.97% |
|
+3.77% | +10.56% |
| Apr. 08 | Olympus to Return Land and Building to Shenzhen City Government | MT |
| Mar. 28 | Olympus Corporation Provides Earnings Guidance for the Fiscal Year Ending March 31, 2024 | CI |
| Sales 2024 * | 930B 6.07B | Sales 2025 * | 990B 6.46B | Capitalization | 2,630B 17.17B |
|---|---|---|---|---|---|
| Net income 2024 * | 258B 1.68B | Net income 2025 * | 113B 735M | EV / Sales 2024 * | 2.74 x |
| Net cash position 2024 * | 78.83B 515M | Net cash position 2025 * | 127B 827M | EV / Sales 2025 * | 2.53 x |
| P/E ratio 2024 * |
10.6
x | P/E ratio 2025 * |
23.6
x | Employees | 32,844 |
| Yield 2024 * |
0.8% | Yield 2025 * |
0.89% | Free-Float | 91.94% |
More Fundamentals
* Assessed data
More news
Latest transcript on Olympus Corporation
More recommendations
More press releases
More news
| 1 day | +2.97% | ||
| 1 week | +3.77% | ||
| Current month | +1.97% | ||
| 1 month | +3.25% | ||
| 3 months | +4.98% | ||
| 6 months | +15.78% | ||
| Current year | +10.56% |
1 week
2 130.00
2 256.00
1 month
2 050.002 293.00
Current year
1 935.502 304.00
1 year
1 782.002 482.50
3 years
1 782.003 198.00
5 years
1 159.003 198.00
10 years
752.503 198.00
| Managers | Title | Age | Since |
|---|---|---|---|
Stefan Kaufmann
CEO | Chief Executive Officer | 56 | 17-03-31 |
Yasuo Takeuchi
CHM | Chairman | 67 | 80-03-31 |
John de Csepel
CTO | Chief Tech/Sci/R&D Officer | - | 23-10-02 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Sumitaka Fujita
BRD | Director/Board Member | 81 | 12-03-31 |
Gary Pruden
BRD | Director/Board Member | 62 | 22-05-31 |
Yasushi Shingai
BRD | Director/Board Member | 68 | - |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 2.83% | 31 M€ | +13.91% | ||
| 2.11% | 11 M€ | +13.64% | - | |
| 1.55% | 251 M€ | +13.17% | ||
| 1.23% | 31,732 M€ | +15.18% | - | |
| 1.22% | 1,198 M€ | +14.37% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-02 | 2,256 | +2.97% | 3,880,400 |
| 24-05-01 | 2,191 | -0.43% | 2,526,800 |
| 24-04-30 | 2,200 | +1.20% | 2,925,300 |
| 24-04-26 | 2,174 | -0.57% | 3,099,200 |
| 24-04-25 | 2,187 | -1.82% | 2,890,300 |
Delayed Quote Japan Exchange, May 02, 2024 at 02:00 am EDT
More quotes
Olympus Corporation specializes in manufacturing and marketing of optical and photographic equipments. Net sales break down by family of products as follows:
- medical equipments (53.1%): surgical endoscopes, ultrasound endoscopes, etc.;
- medical devices (31.7%): medical devices for gastroenterology, urology, respiratory management, ENT and gynecology;
- scientific analysis instruments and microscopes (13.7%);
- other (1.5%): biomedical materials, orthopedic equipment, etc.
Net sales break down geographically as follows: Japan (15.6%), China (14.4%), Asia and Oceania (8.9%), North America (33.8%), Europe (25.1%) and other (2.2%).
Calendar
2024-05-09
- Q4 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
2,256
JPY
Average target price
2,456
JPY
Spread / Average Target
+8.88%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +10.56% | 17.1B | |
| +7.62% | 218B | |
| +6.70% | 183B | |
| +11.94% | 134B | |
| +24.60% | 106B | |
| -2.66% | 61.12B | |
| +4.81% | 50.89B | |
| +11.55% | 51.26B | |
| -1.09% | 40.3B | |
| +26.82% | 32.05B |
- Stock Market
- Equities
- 7733 Stock
